Company news

Mabion SA news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia

August 26, 2026

Other information to the quarterly report of Mabion S.A. for Q1 2026

May 19, 2026

Interim condensed financial statements for the 3-month period ended 31 March 2026

May 19, 2026

Mabion: Financial statements for the financial year ended 31 December 2025

April 29, 2026

Presentation of financial results for FY 2025 – Mabion

April 28, 2026

Mabion: Directors’ Report for the year 2025

April 28, 2026

Directors report for the year 2025

April 28, 2026

Mabion: Condensed interim financial statements as at and for the period of 3 months and 9 months ended 30 September 2025

December 4, 2025

Presentation of financial results for Q3 2025 – Mabion

December 2, 2025

Other information to the quarterly report of Mabion S.A. for Q3 2025

December 1, 2025

Mabion: Condensed Interim Financial Statements for the Period of 6 months ended 30 June 2025

October 8, 2025

Mabion: Condensed interim financial statements for the period of 3 months ended 31 March 2025

June 18, 2025

Directors report for the year 2024

June 16, 2025

Other information to the quarterly report of Mabion S.A. for the first quarter of 2025

June 13, 2025

Mabion: Financial statements for the financial year ended 31 December 2024

May 9, 2025

Other information to the quarterly report of Mabion S.A. for Q3 2024

October 29, 2024

Mabion: Condensed interim financial statements as at and for the period of 3 months and 9 months ended 30 September 2024

October 29, 2024

Mabion: Condensed interim financial statements for the period of 3 months ended 31 March 2024

May 14, 2024

Decks

The 5 newest of 23 decks. Every deck is listed under its year.